25 May 2013
Keywords: BTG, Varisolve, Varicose veins, Ph III
Article | 30 January 2012
UK specialist health care firm BTG (LSE: BGC) has announced the successful outcome of VANISH-2, the first of two US ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 January 2012
31 January 2012
24 May 2013
© 2013 thepharmaletter.com